病気に関連したSHP2変異体の相分離は,MAPK過活性化の原因である.
PubMedで要約を見る
まとめ
この要約は機械生成です。病気に関連したSHP2変異は,液体-液体相分離 (LLPS) を促進することにより,発達障害を引き起こす. SHP2 LLPSを阻害すると,タンパク質チロシンフォスファタゼ (PTP) の活性が回復し,これらの疾患に対する治療戦略を提供することができる.
科学分野
- 生物化学
- 分子生物学
- 遺伝学
背景
- SHP2 (PTPN11) は,発育中のRAS- MAPKシグナル伝達に不可欠な非受容体タンパク質チロシンフォスファターゼである.
- PTPN11変異の活性化と無活性化が重複する発達障害を引き起こし,これは酵素活動だけでは説明できないパラドックスである.
研究 の 目的
- SHP2に関連する発達障害における液体-液体相分離 (LLPS) の役割を調査する.
- 病気に関連したSHP2変異の共通メカニズムであるかどうかを判断する.
- SHP2 LLPSの治療標的を調査する.
主な方法
- LLPSアッセイを用いたSHP2変異者の行動分析
- SHP2 LLPSにおける PTP ドメインの役割を調査した.
- SHP2 LLPSと活性に対するアロステリック阻害剤の影響を評価した.
- LLPS凝縮体内の変異型と野生型SHP2の相互作用を研究した.
主要な成果
- 病気に関連したSHP2変異体は,PTPドメインによって媒介される一般的なLLPS行動を示します.
- SHP2 LLPSは自己抑制メカニズムによって調節され,PTP活性を増強するアロステリック阻害剤によって弱体化することができます.
- LLPSの変異したSHP2は,MAPKシグナル伝達を促進するワイルドタイプのSHP2を募集し,活性化することができます.
結論
- LLPSは,SHP2に関連するヒト疾患における機能増強メカニズムとして作用します.
- LLPSは,タンパク質チロシンファスファターゼ (PTP) の新しい規制メカニズムです.
- SHP2 LLPSをターゲットにすることは,発達障害の潜在的な治療戦略です.
関連する概念動画
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...

